229 related articles for article (PubMed ID: 12395320)
1. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice.
Wolschek MF; Thallinger C; Kursa M; Rössler V; Allen M; Lichtenberger C; Kircheis R; Lucas T; Willheim M; Reinisch W; Gangl A; Wagner E; Jansen B
Hepatology; 2002 Nov; 36(5):1106-14. PubMed ID: 12395320
[TBL] [Abstract][Full Text] [Related]
2. Tissue-dependent factors affect gene delivery to tumors in vivo.
Smrekar B; Wightman L; Wolschek MF; Lichtenberger C; Ruzicka R; Ogris M; Rödl W; Kursa M; Wagner E; Kircheis R
Gene Ther; 2003 Jul; 10(13):1079-88. PubMed ID: 12808438
[TBL] [Abstract][Full Text] [Related]
3. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer.
Kursa M; Walker GF; Roessler V; Ogris M; Roedl W; Kircheis R; Wagner E
Bioconjug Chem; 2003; 14(1):222-31. PubMed ID: 12526712
[TBL] [Abstract][Full Text] [Related]
4. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application.
Kircheis R; Wightman L; Schreiber A; Robitza B; Rössler V; Kursa M; Wagner E
Gene Ther; 2001 Jan; 8(1):28-40. PubMed ID: 11402299
[TBL] [Abstract][Full Text] [Related]
5. Construction of a star-shaped copolymer as a vector for FGF receptor-mediated gene delivery in vitro and in vivo.
Li D; Ping Y; Xu F; Yu H; Pan H; Huang H; Wang Q; Tang G; Li J
Biomacromolecules; 2010 Sep; 11(9):2221-9. PubMed ID: 20704346
[TBL] [Abstract][Full Text] [Related]
6. Amine-reactive pyridylhydrazone-based PEG reagents for pH-reversible PEI polyplex shielding.
Fella C; Walker GF; Ogris M; Wagner E
Eur J Pharm Sci; 2008 Aug; 34(4-5):309-20. PubMed ID: 18586470
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
8. Pegylated immuno-lipopolyplexes: A novel non-viral gene delivery system for liver cancer therapy.
Hu Y; Li K; Wang L; Yin S; Zhang Z; Zhang Y
J Control Release; 2010 May; 144(1):75-81. PubMed ID: 20144670
[TBL] [Abstract][Full Text] [Related]
9. Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody-based gene delivery system.
Mohr L; Schauer JI; Boutin RH; Moradpour D; Wands JR
Hepatology; 1999 Jan; 29(1):82-9. PubMed ID: 9862854
[TBL] [Abstract][Full Text] [Related]
10. Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells.
Merdan T; Callahan J; Petersen H; Kunath K; Bakowsky U; Kopecková P; Kissel T; Kopecek J
Bioconjug Chem; 2003; 14(5):989-96. PubMed ID: 13129403
[TBL] [Abstract][Full Text] [Related]
11. Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface.
Li D; Wang QQ; Tang GP; Huang HL; Shen FP; Li JZ; Yu H
J Zhejiang Univ Sci B; 2006 Nov; 7(11):906-11. PubMed ID: 17048306
[TBL] [Abstract][Full Text] [Related]
12. Nonviral gene transfer into fetal mouse livers (a comparison between the cationic polymer PEI and naked DNA).
Gharwan H; Wightman L; Kircheis R; Wagner E; Zatloukal K
Gene Ther; 2003 May; 10(9):810-7. PubMed ID: 12704421
[TBL] [Abstract][Full Text] [Related]
13. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF
Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484
[TBL] [Abstract][Full Text] [Related]
14. Systemic genetic transfer of p21WAF-1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex.
Liu X; Tian PK; Ju DW; Zhang MH; Yao M; Cao XT; Gu JR
Cancer Gene Ther; 2003 Jul; 10(7):529-39. PubMed ID: 12833133
[TBL] [Abstract][Full Text] [Related]
15. In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector.
Dolivet G; Merlin JL; Barberi-Heyob M; Ramacci C; Erbacher P; Parache RM; Behr JP; Guillemin F
Cancer Gene Ther; 2002 Aug; 9(8):708-14. PubMed ID: 12136433
[TBL] [Abstract][Full Text] [Related]
16. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery.
Ogris M; Brunner S; Schüller S; Kircheis R; Wagner E
Gene Ther; 1999 Apr; 6(4):595-605. PubMed ID: 10476219
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal linear polyethylenimine (L-PEI)-mediated gene delivery to ovarian carcinoma nodes in mice.
Louis MH; Dutoit S; Denoux Y; Erbacher P; Deslandes E; Behr JP; Gauduchon P; Poulain L
Cancer Gene Ther; 2006 Apr; 13(4):367-74. PubMed ID: 16167064
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors.
Carlisle RC; Bettinger T; Ogris M; Hale S; Mautner V; Seymour LW
Mol Ther; 2001 Nov; 4(5):473-83. PubMed ID: 11708884
[TBL] [Abstract][Full Text] [Related]
19. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene.
Yu W; Pirollo KF; Rait A; Yu B; Xiang LM; Huang WQ; Zhou Q; Ertem G; Chang EH
Gene Ther; 2004 Oct; 11(19):1434-40. PubMed ID: 15229629
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
Willhauck MJ; Sharif Samani BR; Klutz K; Cengic N; Wolf I; Mohr L; Geissler M; Senekowitsch-Schmidtke R; Göke B; Morris JC; Spitzweg C
Gene Ther; 2008 Feb; 15(3):214-23. PubMed ID: 17989705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
